Insiders · AAPG

AAPG insider transactions

Ascentage Pharma Group International (AAPG) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for AAPG

• 17d
  Chief Medical Officer Zhai Yifan converted options into 188,321 units of Ordinary Shares, increasing direct ownership by 30% to 405,280 units (SEC Form 4)

  4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 17d
  Chairman and CEO Yang Dajun converted options into 188,321 units of Ordinary Shares, increasing direct ownership by 9% to 1,193,569 units (SEC Form 4)

  4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 48d
  SEC Form 4 filed by Misra Veet

  4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 48d
  SEC Form 3 filed by new insider Misra Veet

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 49d
  Amendment: SEC Form 3 filed by new insider Cao Jin

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 59d
  SEC Form 3 filed by new insider Cao Jin

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  SEC Form 3 filed by new insider Zhai Yifan

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  SEC Form 3 filed by new insider Wei Ren

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Ye Changqing

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Yu Debra

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Lu Simon Dazhong

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Lu Simon Dazhong

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Sidransky David

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  SEC Form 3 filed by new insider Wang Shaomeng

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Lippman Marc E

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  SEC Form 3 filed by new insider Knapp Thomas J

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Yang Dajun

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 77d
  Amendment: SEC Form 3 filed by new insider Bozilenko Marina

  3/A - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Ye Changqing

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Bozilenko Marina

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Yang Dajun

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Sidransky David

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Lu Simon Dazhong

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Lippman Marc E

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
• 81d
  SEC Form 3 filed by new insider Yu Debra

  3 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)